Reportlinker Adds Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017
Apr 21, 2011, 06:09 ET
NEW YORK, April 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017
Summary
GlobalData's medical equipment report, "Brachytherapy Devices - Global Opportunity Assessment, Competitive Landscape and Market Forecasts to 2017" provides key market data on the global brachytherapy market. The report provides global market value (USD million) for the two market categories – permanent brachytherapy devices and temporary brachytherapy devices. The report is a key source for the current market trends and technology trends for brachytherapy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key categories covered include – permanent brachytherapy devices and temporary brachytherapy devices.
- Annualized market revenues data for 2002 to 2010, forecast forward for 7 years to 2017.
- In-depth market trend analysis for brachytherapy market.
- 2010 company shares for permanent and temporary brachytherapy devices markets.
- Geographic sales break up for 2010 sales: North America, Europe and Rest of the World
- In-depth analysis of key players in the brachytherapy devices market- Oncura, CR Bard, Core Oncology, Theragenics, Ibt Bebig, Varian and Nucletron.
- Key mergers and acquisitions as well as key partnerships in the global brachytherapy devices market.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the brachytherapy devices market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the brachytherapy devices market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global brachytherapy devices market and the factors shaping it.
Table of Contents
1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 GlobalData Report Guidance 6
3 Disease Overview: Cancer 7
3.1 Introduction 7
3.2 Etiology, Signs and Symptoms of Cancer 7
3.2.1 Etiology of Cancer (Risk Factors of Cancer) 7
3.2.2 Pathophysiology 10
3.2.3 Signs and Symptoms of Cancer 11
3.3 Epidemiology of Cancer 12
3.3.1 Incidence of Cancer 12
3.3.2 Mortality and Survival Rates 15
3.4 Treatment Flow Model for Brachytherapy for Cancer 15
3.4.1 Diseased Patient Population 16
3.4.2 Treatment seeking rate 16
3.4.3 Diagnosis rate 16
3.4.4 Prescription rate 16
3.5 Cancer Staging 17
3.6 Device Based Treatment Modalities 18
3.6.1 Internal Radiation Therapy or Brachytherapy 19
3.7 Profile of Common Types of Cancer Treated by Brachytherapy 21
3.7.1 Prostate Cancer 21
3.7.2 Breast Cancer 26
4 Brachytherapy Devices: Market Characterization 29
4.1 Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2003-2010 29
4.2 Brachytherapy Devices Market, Global, Revenue ($m), Forecasts, 2010-2017 30
4.3 Brachytherapy Devices Market, Global, Category Analysis, 2003–2017 31
4.3.1 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2003-2010 31
4.3.2 Permanent Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 2010-2017 32
4.3.3 Permanent Brachytherapy Devices Market, Global, Company Share (%), 2010 33
4.3.4 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Historic, 2003-2010 34
4.3.5 Temporary Brachytherapy Devices Market, Global, Revenue ($m), Forecast, 2010-2017 35
4.3.6 Temporary Brachytherapy Devices Market, Global, Company Share (%), 2010 36
4.4 Brachytherapy Devices Market, Geographic Assessment, 2010 37
4.5 Brachytherapy Devices Market, Global, Key Technology Trends 38
4.5.1 New Treatment Planning Software Reduces Treatment Time and Improves Efficiency 38
4.5.2 Innovative Afterloaders to Reduce Handling Time and Improve Cost Efficiency 38
4.5.3 New Radioisotopes with Short Lives 39
4.5.4 Image Guided Brachytherapy 39
4.6 Brachytherapy Devices, Market Dynamics 40
4.6.1 Market Drivers 40
4.6.2 Market Restraints 43
5 Brachytherapy Devices Market: Strategic Competitive Assessment 44
5.1 Oncura 44
5.1.1 Overview 44
5.1.2 Marketed Products 44
5.1.3 SWOT Analysis 44
5.2 CR Bard 46
5.2.1 Overview 46
5.2.2 Financial Profile 47
5.2.3 Marketed Products 47
5.2.4 SWOT Analysis 47
5.3 Nucletron 48
5.3.1 Overview 48
5.3.2 Financial Overview 48
5.3.3 Marketed Products 49
5.3.4 SWOT Analysis 49
5.4 Theragenics 52
5.4.1 Overview 52
5.4.2 Financial Overview 52
5.4.3 Marketed Products 52
5.4.4 SWOT Analysis 52
5.5 IBt Bebig 54
5.5.1 Overview 54
5.5.2 Marketed Products 54
5.5.3 Financial Overview 54
5.5.4 SWOT Analysis 54
5.6 Varian 56
5.6.1 Overview 56
5.6.2 Financial Overview 56
5.6.3 Marketed Products 57
5.6.4 SWOT Analysis 57
6 Brachytherapy Devices, Key Marketed Device Profiles 61
6.1 OncoSeed 61
6.2 EchoSeed 61
6.3 BrachySource I-125 implant 61
6.4 ProstaSeed I-125 61
6.5 TheraSeed-Pd 103 61
6.6 I-Seed 62
6.7 VariSource iX Afterloader 62
6.8 GammaMedplus iX Afterloader 62
6.9 microSelectron Digital 62
7 Global Brachytherapy Market: Deals Landscape 63
7.1 Key Acquisitions 63
7.1.1 IBt Bebig acquires SonoTECH GmbH 63
7.1.2 CR Bard to Merge with SenoRx, Inc. 63
7.1.3 iCAD Completes Acquisition of Xoft 64
7.1.4 BTG International to Acquire Biocompatibles 64
7.1.5 International Brachytherapy Acquires BEBIG from Eckert & Ziegler Isotope Products 65
7.2 Partnerships 65
7.2.1 Theragenics Enters into Distribution Agreement with Oncura 65
7.2.2 IsoRay Enters into Exclusive Licensing Agreement with Hologic 65
7.2.3 Theragenics Signs an Agreement with Core Oncology 66
7.2.4 Nucletron Merges with Isodose Control 66
7.2.5 IsoRay Enters into a Distribution Agreement with Biocompatibles International 66
7.2.6 Sirtex Medical Signs Agreement with Peter MacCallum Cancer Centre 66
7.2.7 Sirtex Medical Signs Licensing Agreement with Synmosa Biopharma 67
7.2.8 Sirtex Medical Signs Licensing Marketing Agreement with HOIN MEDIBIZ 67
8 Appendix 68
8.1 Definitions 69
8.1.1 Radiation Therapy Devices 69
8.1.2 Brachytherapy Devices 69
8.1.3 Permanent Brachytherapy Devices 69
8.1.4 Temporary Brachytherapy Devices 69
8.2 Acronyms 70
8.3 Sources 70
8.3.1 Cancer Associations and Organizations 70
8.3.2 Online Journals, Websites and Trade Magazines 70
8.3.3 News Publications 70
8.3.4 Company Websites, Financial Reports, Investor Presentations and Investor Calls 70
8.4 Research Methodology 71
8.5 Secondary Research 71
8.6 Primary Research 71
8.7 Models 72
8.8 Forecasts 72
8.9 Expert Panels 72
8.10 GlobalData Consulting 72
8.11 Contact Us 73
8.12 Disclaimer 73
List of Tables
1.1 List of Tables
Table 1: Risk Factors for Cancer, by Geography (%), 2008 9
Table 2: Incidence of Cancer, Global, Population (million), 2008–2050 12
Table 3: New Cancer Cases by Type, Global, Male Population, 2008 13
Table 4: New Cancer Cases by Type, Global, Female Population, 2008 14
Table 5: TNM Tumor Staging 17
Table 6: Cancer Staging 18
Table 7: Cancer Staging, SEER Classification 18
Table 8: Brachytherapy Classification 19
Table 9: Brachytherapy Devices Market, Global, Revenue ($m), 2003–2010 29
Table 10: Brachytherapy Devices Market, Global, Revenue ($m), 2010–2017 30
Table 11: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2003–2010 31
Table 12: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2010–2017 32
Table 13: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2003–2010 34
Table 14: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2010–2017 35
Table 15: Brachytherapy Devices Market, Geographic Share (%), 2010 37
Table 16: Incidence of Cancer, Global, Population (000s), 2002–2020 40
Table 17: Oncura, Brachytherapy, Marketed Products, 2010 44
Table 18: CR Bard, Marketed Products, 2010 47
Table 19: Nucletron, Marketed Products, 2010 49
Table 20: IBt Bebig, Marketed Products, 2010 54
Table 21: Varian, Brachytherapy, Marketed Products, 2010 57
List of Figures
1.2 List of Figures
Figure 1: Risk Factors for Cancer (%), 2008 9
Figure 2: Incidence of Cancer, Global, Population (million), 2008–2050 12
Figure 3: New Cancer Cases by Type, Global, Male Population (%), 2008 13
Figure 4: New Cancer Cases by Type, Global, Female Population (%), 2008 14
Figure 5: Treatment Flow Model for Brachytherapy for Cancer, Global, 2010 15
Figure 6: Brachytherapy Devices Market, Global, Revenue ($m), 2003–2010 29
Figure 7: Brachytherapy Devices Market, Global, Revenue ($m), 2010–2017 30
Figure 8: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2003–2010 31
Figure 9: Permanent Brachytherapy Devices Market, Global, Revenue ($m), 2010–2017 32
Figure 10: Permanent Brachytherapy Devices Market, Global, Company Share (%), 2010 33
Figure 11: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2003–2010 34
Figure 12: Temporary Brachytherapy Devices Market, Global, Revenue ($m), 2010–2017 35
Figure 13: Temporary Brachytherapy Devices Market, Global, Company Share (%), 2010 36
Figure 14: Brachytherapy Devices Market, Geographic Share (%), 2010 37
Figure 15: Incidence of Cancer, Global, Population (000s), 2002–2020 40
Figure 16: Oncura, SWOT Analysis, 2010 44
Figure 17: CR Bard, SWOT Analysis, 2010 47
Figure 18: Nucletron, SWOT Analysis, 2010 49
Figure 19: Nucletron, New Product Launches, 2007–2010 51
Figure 20: Theragenics, SWOT Analysis, 2010 52
Figure 21: IBt Bebig, SWOT Analysis, 2010 54
Figure 22: Varian, SWOT Analysis, 2010 57
Figure 23: Varian, Product Launches, 2007–2010 59
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker